Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Findings reported from REFLEX and MOSAIC trials of IFN-beta1a

Nov. 7, 2011

Ondansetron is effective in treating diarrhea-predominant irritable bowel syndrome

Nov. 4, 2011

Boceprevir improves hepatitis C treatment in patients coinfected with HIV

Nov. 4, 2011

Phosphodiesterase 5 inhibitor improves portal hypertension in open-label trial

Nov. 4, 2011

Long-term daclizumab therapy analyzed in patients with MS

Nov. 4, 2011

New therapeutic approach suggested for achalasia / News in Context

Nov. 3, 2011

Candidate vaccine for CDI-associated diarrhea is immunogenic and well tolerated

Nov. 3, 2011

Potential new target for MS therapy discovered at U.S. univeristy

Nov. 3, 2011

Initial treatment phase of rabeprazole trial in pediatric patients completed

Nov. 3, 2011

Additional data disclosed from ALLEGRO and BRAVO trials of laquinimod in RRMS

Nov. 3, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...